Reaction
Facial Wasting reporting signals
As of the last recalculation, Facial Wasting appears in 263 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is ABACAVIR SULFATE (PRR 138.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Abacavir Sulfate | 16 | 138.3 | 138.6 |
| Meperidine Hydrochloride | 10 | 89.3 | 89.3 |
| Zidovudine | 14 | 87.5 | 87.6 |
| Atazanavir | 14 | 81.4 | 81.5 |
| Lamivudine | 26 | 73.8 | 73.9 |
| Ritonavir 100 Mg | 13 | 72.4 | 72.5 |
| Lopinavir And Ritonavir | 10 | 60.7 | 60.7 |
| Efavirenz | 8 | 58.5 | 58.6 |
| Lamivudine Oral | 17 | 56.8 | 56.8 |
| Ritonavir | 17 | 49.2 | 49.2 |
| Nevirapine | 4 | 35.6 | 35.6 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 3 | 23.9 | 23.9 |